Nonoperating Income (Expense) of CRESCENT BIOPHARMA, INC. from 31 Mar 2013 to 31 Dec 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
CRESCENT BIOPHARMA, INC. annual and quarterly Nonoperating Income (Expense) in USD history and change rate from 31 Mar 2013 to 31 Dec 2024.
  • CRESCENT BIOPHARMA, INC. Nonoperating Income (Expense) for the quarter ending 30 Sep 2024 was $1,409,465, a 131% increase year-over-year.
  • CRESCENT BIOPHARMA, INC. annual Nonoperating Income (Expense) for 2024 was $2,160,220, a 9.1% decline from 2023.
Source SEC data
View on sec.gov
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Change (%)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Change (%)

CRESCENT BIOPHARMA, INC. Annual Nonoperating Income (Expense) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $2,160,220 -$215,653 -9.1% 01 Jan 2024 31 Dec 2024 10-K 13 Feb 2025 2024 FY
2023 $2,375,873 01 Jan 2023 31 Dec 2023 10-K 13 Feb 2025 2024 FY

CRESCENT BIOPHARMA, INC. Quarterly Nonoperating Income (Expense) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2024 $1,409,465 +$798,487 +131% 01 Jul 2024 30 Sep 2024 10-Q 13 Nov 2024 2024 Q3
Q3 2023 $610,978 01 Jul 2023 30 Sep 2023 10-Q 13 Nov 2024 2024 Q3
Q1 2014 $4,773 -$960,227 -100% 01 Jan 2014 31 Mar 2014 10-Q 09 May 2014 2014 Q1
Q1 2013 $965,000 01 Jan 2013 31 Mar 2013 10-Q 09 May 2014 2014 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.